The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes.

Source:http://linkedlifedata.com/resource/pubmed/id/16297978

Download in:

View as

General Info

PMID
16297978